Accelerate Diagnostics

Accelerate Diagnostics

Employees:
190
Market Cap:
$1.11 billion
Revenue:
$246 thousand
5 Year Trend:
24.3%
Net Income:
$-65.54 million
NASDAQ:
AXDX

Accelerate Diagnostics

Employees:
190
Market Cap:
$1.11 billion
Revenue:
$246 thousand
5 Year Trend:
24.3%
Net Income:
$-65.54 million
NASDAQ:
AXDX
  • Mar 3 at 1:00 AM
    We're proud to announce The University Hospital in Augusta, GA, became the first hospital in the U.S. to adopt the Accelerate Pheno system and kit! www.axdx.com/FDA L-R: University Hospital: Kailash Sharma, MD, Medical Director of Laboratory Services; William Farr, MD, Chief Medical Officer; James Davis, Chief Executive Officer; Christa Pardue, Director of Laboratory Services; Scott Ansede, Vice President, Professional Support Services; David King, Microbiology Laboratory Manager Accelerate Diagnostics: John Prichard, Applications Specialist; Travis Musick, Commercial Development Director University Hospital: Adrienne Albrecht, R.PH., Clinical Pharmacy Specialist; Marie Jackson, PharmD, Director of Pharmacy Accelerate Diagnostics: Ron Price, Senior Vice President, Head of North American
  • Mar 1 at 0:00 PM
    The Centers for Disease Control and Prevention (CDC) recommends hospitals improve antibiotic usage by prescribing antimicrobials only when needed. Using the FDA-cleared Accelerate Pheno system and PhenoTest BC kit solution, laboratories can get definitive results and clinicians can provide optimal therapy to seriously ill patients up to 40 hours faster than conventional methods. http://buff.ly/2liL9jI
  • Mar 1 at 0:00 PM
    The Centers for Disease Control and Prevention (CDC) recommends hospitals improve antibiotic usage by prescribing antimicrobials only when needed. Using the FDA-cleared Accelerate Pheno system and PhenoTest BC kit solution, laboratories can get definitive results and clinicians can provide optimal therapy to seriously ill patients up to 40 hours faster than conventional methods. http://buff.ly/2liL9jI
  • Feb 28 at 1:00 AM
    Early diagnosis of antibiotic resistant bacteria is critical to providing sepsis patients optimal therapy. Typical, conventional antibiotic susceptibility testing requires time consuming manual procedures, resulting in laboratory processing time that often exceeds 48 hours, leaving clinicians with incomplete information to provide definitive treatment during this critical timeframe. Using the FDA-cleared Accelerate Pheno system and PhenoTest BC kit, labs can get definitive results and clinicians can provide optimal therapy to seriously ill patients 1-2 days faster than conventional methods.

Mar 3, 1:00 AM

We're proud to announce The University Hospital in Augusta, GA, became the first hospital in the U.S. to adopt the Accelerate Pheno system and kit! www.axdx.com/FDA L-R: University Hospital: Kailash Sharma, MD, Medical Director of Laboratory Services; William Farr, MD, Chief Medical Officer; James Davis, Chief Executive Officer; Christa Pardue, Director of Laboratory Services; Scott Ansede, Vice President, Professional Support Services; David King, Microbiology Laboratory Manager Accelerate Diagnostics: John Prichard, Applications Specialist; Travis Musick, Commercial Development Director University Hospital: Adrienne Albrecht, R.PH., Clinical Pharmacy Specialist; Marie Jackson, PharmD, Director of Pharmacy Accelerate Diagnostics: Ron Price, Senior Vice President, Head of North American

Mar 1, 0:00 PM

The Centers for Disease Control and Prevention (CDC) recommends hospitals improve antibiotic usage by prescribing antimicrobials only when needed. Using the FDA-cleared Accelerate Pheno system and PhenoTest BC kit solution, laboratories can get definitive results and clinicians can provide optimal therapy to seriously ill patients up to 40 hours faster than conventional methods. http://buff.ly/2liL9jI

Mar 1, 0:00 PM

The Centers for Disease Control and Prevention (CDC) recommends hospitals improve antibiotic usage by prescribing antimicrobials only when needed. Using the FDA-cleared Accelerate Pheno system and PhenoTest BC kit solution, laboratories can get definitive results and clinicians can provide optimal therapy to seriously ill patients up to 40 hours faster than conventional methods. http://buff.ly/2liL9jI

Feb 28, 1:00 AM

Early diagnosis of antibiotic resistant bacteria is critical to providing sepsis patients optimal therapy. Typical, conventional antibiotic susceptibility testing requires time consuming manual procedures, resulting in laboratory processing time that often exceeds 48 hours, leaving clinicians with incomplete information to provide definitive treatment during this critical timeframe. Using the FDA-cleared Accelerate Pheno system and PhenoTest BC kit, labs can get definitive results and clinicians can provide optimal therapy to seriously ill patients 1-2 days faster than conventional methods.